Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MD 
Mednax Inc (MD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/08/2025: MD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -18.9% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/08/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.21B USD | Price to earnings Ratio - | 1Y Target Price 18.36 |
Price to earnings Ratio - | 1Y Target Price 18.36 | ||
Volume (30-day avg) 739037 | Beta 1.33 | 52 Weeks Range 6.62 - 17.67 | Updated Date 04/10/2025 |
52 Weeks Range 6.62 - 17.67 | Updated Date 04/10/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.14 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.92% | Operating Margin (TTM) 11.57% |
Management Effectiveness
Return on Assets (TTM) 5.25% | Return on Equity (TTM) -12.28% |
Valuation
Trailing PE - | Forward PE 9.06 | Enterprise Value 1523825036 | Price to Sales(TTM) 0.6 |
Enterprise Value 1523825036 | Price to Sales(TTM) 0.6 | ||
Enterprise Value to Revenue 0.76 | Enterprise Value to EBITDA 69.27 | Shares Outstanding 85816896 | Shares Floating 82802321 |
Shares Outstanding 85816896 | Shares Floating 82802321 | ||
Percent Insiders 1.78 | Percent Institutions 101.12 |
Analyst Ratings
Rating 3.75 | Target Price 16.21 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold 5 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Mednax Inc
Company Overview
History and Background
Mednax Inc., now known as Pediatrix Medical Group, was founded in 1979. It initially focused on providing neonatal physician services and has grown through acquisitions to become a leading provider of specialized medical services.
Core Business Areas
- Pediatrix & Obstetrix Medical Group: Provides physician services, including newborn, maternal-fetal, and pediatric subspecialty care.
- MEDNAX Radiology Solutions: Offers radiology and teleradiology services.
Leadership and Structure
The leadership team includes Mark Ordan (CEO). The organizational structure is based on specialized medical service lines.
Top Products and Market Share
Key Offerings
- Newborn Care: Provision of neonatal intensive care unit (NICU) services, including staffing, management, and clinical care. Market share data is difficult to ascertain precisely, as it involves multiple local and regional markets. Competitors include hospital-employed physicians and other national physician groups. Revenue information is not consistently broken down by service within financial reports.
- Maternal-Fetal Medicine: Specialized care for high-risk pregnancies. Market share data is not easily available, but Pediatrix has a significant presence in many regions. Competitors include large hospital systems, private practices, and other national providers. Revenue information is not consistently broken down by service within financial reports.
- Pediatric Subspecialty Services: Offers services across a variety of pediatric subspecialties. Market share varies by subspecialty and geographic area. Revenue data is not precisely broken down.
Market Dynamics
Industry Overview
The healthcare services industry is characterized by increasing demand for specialized medical care, driven by aging populations and technological advancements. The industry is highly regulated and subject to changes in reimbursement models.
Positioning
Pediatrix Medical Group is positioned as a national leader in specialized medical services for newborns, children, and expectant mothers. Its competitive advantages include a large network of physicians and established relationships with hospitals.
Total Addressable Market (TAM)
The total addressable market for specialized pediatric and maternity care services is substantial and growing, estimated to be in the billions of dollars annually. Pediatrix is positioned to capture a significant portion through its national footprint and specialized expertise.
Upturn SWOT Analysis
Strengths
- National network of physicians
- Established relationships with hospitals
- Specialized expertise in neonatal and maternal-fetal medicine
- Economies of Scale
Weaknesses
- High operating costs
- Reliance on third-party payers (insurance companies)
- Vulnerability to changes in reimbursement models
- Acquisition integration challenges
Opportunities
- Expansion into new geographic markets
- Development of new service lines
- Increased focus on value-based care
- Strategic partnerships with other healthcare providers
Threats
- Increasing competition from hospital-employed physicians
- Changes in government regulations
- Rising malpractice insurance costs
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- Team Health (Private)
- Envision Healthcare (Private)
- HCA Healthcare (HCA)
Competitive Landscape
Mednax has advantages in its specialized focus, but faces competition from larger hospital systems and other physician groups. Envision and TeamHealth are privately held so market share data is more difficult to acquire.
Major Acquisitions
NightLight Pediatric Urgent Care
- Year: 2018
- Acquisition Price (USD millions): 53
- Strategic Rationale: Expanded Mednax's pediatric service offerings beyond the acute hospital setting and into the urgent care market.
Growth Trajectory and Initiatives
Historical Growth: Mednax has grown historically through acquisitions and organic growth in specialized medical service lines.
Future Projections: Analyst projections vary but generally anticipate continued growth in revenue and earnings, driven by increasing demand for specialized medical care.
Recent Initiatives: Recent initiatives include focusing on improving operational efficiency and expanding service offerings.
Summary
Pediatrix Medical Group is a leading provider of specialized medical services, particularly in newborn and maternal-fetal medicine. While its strong network and expertise are key strengths, high operating costs and reliance on third-party payers present challenges. Future growth depends on successful expansion into new markets and service lines, alongside navigating evolving reimbursement models and competition from hospitals. Despite not currently paying dividends, it reinvests for growth.
Similar Companies
HCA
HCA Holdings Inc
HCA
HCA Holdings Inc
USPH
US Physicalrapy Inc
USPH
US Physicalrapy Inc
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry Publications
- Financial Websites (e.g., Yahoo Finance, Bloomberg)
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions and company performance can change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mednax Inc
Exchange NYSE | Headquaters Sunrise, FL, United States | ||
IPO Launch date 1995-09-19 | CEO & Executive Chairman Mr. Mark S. Ordan | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 4120 | Website https://www.pediatrix.com |
Full time employees 4120 | Website https://www.pediatrix.com | ||
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.